Pure red-cell aplasia requiring cytotoxic chemotherapy: presence of clonal T-lymphocytes without characteristics of chronic lymphocytic leukemia.
M
M
Nezu
E
E
Kawano
H
H
Ishii
M
M
Nishimura
A
A
Hirasawa
S
S
Hashimoto
S
S
Morio
N
N
Aotsuka
H
H
Nakamura
T
T
Asai
Y
Y
Saito
H
H
Oh
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002999:Clone Cells / Q000276:immunology; D003520:Cyclophosphamide / Q000008:administration & dosage; D003602:Cytotoxicity, Immunologic; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D012010:Red-Cell Aplasia, Pure / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone